Literature DB >> 26810346

Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.

Jan P Radtke1, Constantin Schwab2, Maya B Wolf3, Martin T Freitag3, Celine D Alt4, Claudia Kesch2, Ionel V Popeneciu2, Clemens Huettenbrink2, Claudia Gasch2, Tilman Klein2, David Bonekamp3, Stefan Duensing5, Wilfried Roth6, Svenja Schueler7, Christian Stock7, Heinz-Peter Schlemmer3, Matthias Roethke3, Markus Hohenfellner2, Boris A Hadaschik2.   

Abstract

BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) and MRI fusion targeted biopsy (FTB) detect significant prostate cancer (sPCa) more accurately than conventional biopsies alone.
OBJECTIVE: To evaluate the detection accuracy of mpMRI and FTB on radical prostatectomy (RP) specimen. DESIGN, SETTING AND PARTICIPANTS: From a cohort of 755 men who underwent transperineal MRI and transrectal ultrasound fusion biopsy under general anesthesia between 2012 and 2014, we retrospectively analyzed 120 consecutive patients who had subsequent RP. All received saturation biopsy (SB) in addition to FTB of lesions with Prostate Imaging Reporting and Data System (PI-RADS) score ≥2. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The index lesion was defined as the lesion with extraprostatic extension, the highest Gleason score (GS), or the largest tumor volume (TV) if GS were the same, in order of priority. GS 3+3 and TV ≥1.3ml or GS ≥3+4 and TV ≥0.55ml were considered sPCa. We assessed the detection accuracy by mpMRI and different biopsy approaches and analyzed lesion agreement between mpMRI and RP specimen. RESULTS AND LIMITATIONS: Overall, 120 index and 71 nonindex lesions were detected. Overall, 107 (89%) index and 51 (72%) nonindex lesions harbored sPCa. MpMRI detected 110 of 120 (92%) index lesions, FTB (two cores per lesion) alone diagnosed 96 of 120 (80%) index lesions, and SB alone diagnosed 110 of 120 (92%) index lesions. Combined SB and FTB detected 115 of 120 (96%) index foci. FTB performed significantly less accurately compared with mpMRI (p=0.02) and the combination for index lesion detection (p=0.002). Combined FTB and SB detected 97% of all sPCa lesions and was superior to mpMRI (85%), FTB (79%), and SB (88%) alone (p<0.001 each). Spearman's rank correlation coefficient for index lesion agreement between mpMRI and RP was 0.87 (p<0.001). Limitations included the retrospective design, multiple operators, and nonblinding of radiologists.
CONCLUSIONS: MpMRI identified 92% of index lesions compared with RP histopathology. The combination of FTB and SB was superior to both approaches alone, reliably detecting 97% of sPCa lesions. PATIENT
SUMMARY: Multiparametric magnetic resonance imaging detects the index lesion accurately in 9 of 10 patients; however, the combined biopsy approach, while missing less significant cancer, comes at the cost of detecting more insignificant cancer.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biopsy; Cancer volume; Image fusion; Index tumor; Magnetic resonance imaging; Predictive values; Prostate cancer; Radical prostatectomy; Ultrasound

Mesh:

Year:  2016        PMID: 26810346     DOI: 10.1016/j.eururo.2015.12.052

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  62 in total

1.  Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.

Authors:  Nima Nassiri; Daniel J Margolis; Shyam Natarajan; Devi S Sharma; Jiaoti Huang; Frederick J Dorey; Leonard S Marks
Journal:  J Urol       Date:  2016-09-14       Impact factor: 7.450

Review 2.  Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Authors:  Armando Stabile; Francesco Giganti; Andrew B Rosenkrantz; Samir S Taneja; Geert Villeirs; Inderbir S Gill; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2019-07-17       Impact factor: 14.432

Review 3.  [MRI/TRUS fusion-guided prostate biopsy : Value in the context of focal therapy].

Authors:  T Franz; J von Hardenberg; A Blana; H Cash; D Baumunk; G Salomon; B Hadaschik; T Henkel; J Herrmann; F Kahmann; K-U Köhrmann; J Köllermann; S Kruck; U-B Liehr; S Machtens; I Peters; J P Radtke; A Roosen; H-P Schlemmer; L Sentker; J J Wendler; U Witzsch; J-U Stolzenburg; M Schostak; R Ganzer
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

Review 4.  [Prostate gland - what would urologists like to know from radiologists?]

Authors:  U B Liehr; D Baumunk; S Blaschke; F Fischbach; B Friebe; F König; A Lemke; P Mittelstädt; M Pech; M Porsch; J Ricke; D Schindele; S Siedentopf; J J Wendler; M Schostak
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

Review 5.  The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa).

Authors:  Parth Patel; Shu Wang; Mohummad Minhaj Siddiqui
Journal:  Curr Urol Rep       Date:  2019-09-02       Impact factor: 3.092

Review 6.  Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions.

Authors:  Hüseyin Cihan Demirel; John Warren Davis
Journal:  Turk J Urol       Date:  2018-03-01

Review 7.  Score 3 prostate lesions: a gray zone for PI-RADS v2.

Authors:  Michele Scialpi; Eugenio Martorana; Maria Cristina Aisa; Valeria Rondoni; Alfredo D'Andrea; Giampaolo Bianchi
Journal:  Turk J Urol       Date:  2017-08-03

Review 8.  Biparametric MRI of the prostate.

Authors:  Michele Scialpi; Alfredo D'Andrea; Eugenio Martorana; Corrado Maria Malaspina; Maria Cristina Aisa; Maria Napoletano; Emanuele Orlandi; Valeria Rondoni; Pietro Scialpi; Diamante Pacchiarini; Diego Palladino; Michele Dragone; Giancarlo Di Renzo; Annalisa Simeone; Giampaolo Bianchi; Luca Brunese
Journal:  Turk J Urol       Date:  2017-12-01

9.  Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.

Authors:  Daniel I Glazer; Elmira Hassanzadeh; Andriy Fedorov; Olutayo I Olubiyi; Shayna S Goldberger; Tobias Penzkofer; Trevor A Flood; Paul Masry; Robert V Mulkern; Michelle S Hirsch; Clare M Tempany; Fiona M Fennessy
Journal:  Abdom Radiol (NY)       Date:  2017-03

10.  Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

Authors:  Julie Y An; Stephanie A Harmon; Sherif Mehralivand; Marcin Czarniecki; Clayton P Smith; Julie A Peretti; Bradford J Wood; Peter A Pinto; Peter L Choyke; Joanna H Shih; Baris Turkbey
Journal:  Abdom Radiol (NY)       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.